Displaying drugs 5351 - 5375 of 5959 in total
Allysine
Experimental
Phlorizin
Experimental
Ginisortamab
Ginisortamab is under investigation in clinical trial NCT04393298 (A Study to Assess the Safety, Pharmacokinetics and Anti Tumor Activity of UCB6114 Administered Intravenously to Participants With Advanced Solid Tumors).
Investigational
Arimoclomol
Arimoclomol is an experimental drug compound developed by CytRx Corporation, a biopharmaceutical company based in Los Angeles, California. The orally administered drug is intended to treat amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, a neurodegenerative disease with no effective treatment.
Investigational
Orvacabtagene autoleucel
Investigational
Azenosertib
Investigational
Zoptarelin doxorubicin
Zoptarelin doxorubicin has been used in trials studying the treatment of Breast Cancer, Ovarian Cancer, Prostate Cancer, Endometrial Cancer, and Urothelial Carcinoma, among others.
Investigational
Equilin
An estrogenic steroid produced by horses. It has a total of four double bonds in the A- and B-ring. High concentration of equilin is found in the urine of pregnant mares.
Experimental
3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole
Experimental
ADH-503
Investigational
5-(2-Chlorophenyl)Furan-2-Carboxylic Acid
Experimental
2'-fluoro-2'-deoxyuridine 3'-monophosphate
Experimental
Displaying drugs 5351 - 5375 of 5959 in total